Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 4 (IL-4) is a cytokine that plays a central role in regulating humoral and adaptive immunity. It is primarily secreted by mast cells, Th2 cells, eosinophils, and basophils. IL-4 is crucial for Th2 cell differentiation and promotes IgE production, leading to allergic inflammation. Targeting IL-4 or its receptor is a therapeutic strategy for treating allergic diseases.
IL-4 inhibitors block the binding of IL-4 to its receptor, preventing downstream signaling and reducing the inflammatory response. Some therapies target the receptor itself.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 4 (IL-4).